Spotlight Medical, a Paris, France-based startup developing AI-driven prognosis tests, raised €6.2M in Seed funding.
The round was led by Kurma Partners and Heal Capital.
Led by CEO Sylvain Berlemont, Spotlight Medical is a precision medicine company advancing AI tests that enhance treatment selection by leveraging decades of patient data. This ensures personalized and effective care for each individual, significantly improving patient outcomes and quality of life.
The company intends to use the funds to bring its first prognosis test to the clinic, marking a significant milestone in the commercialization of AI-based solutions for cancer treatment.
FinSMEs
12/07/2024